HD-OPM Archive
Topics › PCSK9, ezetimibe & newer drugs

PCSK9 gene-editing therapy may not be safe yet; patient deaths occurred in a trial

Louis Nervegna · Mar 18, 2025 · ♥ 22 reactions · 24 comments · original Facebook post
PCSK9, ezetimibe & newer drugsLDL, ApoB & lipid panel
AI summary & key facts

Louis warns that experimental PCSK9 gene therapies for lowering LDL may be unsafe because people have died in trials, and notes that safe, effective drugs already exist, including PCSK9 inhibitors. He clarifies that the deaths were specific to the gene therapy in that trial, with unclear cause, and were not seen in long PCSK9 inhibitor drug trials.

PCSK9 gene therapies to lower LDL may not be safe.

People have died in the trials.

We have safe drugs that lower LDL very effectively, including drugs that safely inhibit PCSK9.

For most people, there is no good reason to take the risk of gene therapy to lower LDL until it is approved by the FDA and proven safe.


Please note:

These deaths were very specific to the gene therapy in this particular trial. The cause is unclear.

Nothing like this was seen in large long-running drug trials for PCSK9 inhibitors.

#genetherapyHD #pcsk9HD #verve102HD #verve101HD

FuturismPatient Dies After Being Gene-Edited to Have Lower CholesterolResearchers have reduced the level of bad cholesterol in human subjects after injecting them with an experimental gene editing treatment.futurism.com

Research cited

← newer: JAMA Intern Med: statin use linked to lower liver cancer andolder: Heart attack clots form on ruptured unstable plaque, not in →